Tuberculosis and iron overload in Africa: A review

Central African Journal of Medicine

Volumn 43, Issue 11, 1997, Pages 334-339

  Moyo, V M ^a   Gangaidzo, I T ^a   Gordeuk, V R ^b   Kiire, C F ^c   Macphail, A P ^d  

^a UNIV OF ZIMBABWE MEDICAL SCHOOL   (Zimbabwe)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c SOUTHPORT AND ORMSKIRK HOSPITAL NHS TRUST   (United Kingdom)

^d UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICA; AIDS RELATED COMPLEX; COMORBIDITY; HEMOSIDEROSIS; HUMAN; IMMUNOLOGY; LUNG TUBERCULOSIS; MACROPHAGE; REVIEW; RISK FACTOR; T LYMPHOCYTE;

ADULT; AFRICA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COMORBIDITY; HEMOSIDEROSIS; HUMANS; MACROPHAGES; RISK FACTORS; T-LYMPHOCYTES; TUBERCULOSIS, PULMONARY;

EID: 0031267834     PISSN: 00089176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Trousseau A. True and false chlorosis. In: Lectures on clinical medicine. Philadelphia: Lindsay and Blakiston, PA, 1872: 95-117.
2. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organisation. Tubercle 1991;72:1-6.
3. Sudre P, ten Dam G, Kochi A. Tuberculosis: a global overview of the situation today. Bull WHO 1992;70:149-59.
4. WHO Proceedings on the Informal Meeting. Development of guidelines for tuberculosis control in HIV epidemic countries/areas. Geneva: WHO Tuberculosis Unit Publication, 1989.
5. De Cock KM, Soro B, Coulibay IM, Lucas SB. Tuberculosis and HIV infection in sub-Saharan Africa. J Am Med Assoc 1992;284:387-92.
6. Chaisson RE, Johnson MP. Tuberculosis and HIV infection. AIDS Clinical Care 1991; 3:1-3.
7. Murray JF. A cursed duo: HIV and tuberculosis. Bull Acad Natl Med 1991;175:471-93.
8. Perriens JH, Colebunders RL, Karahunga C, Willame J, Jeugmans J, Kaboto M, et al. Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared to HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshansa, Zaire. Am Rev Respir Dis 1991;144:750-5.
9. Gollapudi M, Reddy M, Gangadharam P, Tsuruo T, Gupta S. Mycobacterium tuberculosis induces expression of P-glycoprotein in promonocytic U1 cells chronically infected with HIV type 1. Biochemical and Biophysical Research Communications 1994; 199:1181-7.
10. Ledermann MM, Georges DL, Kusner DJ, Mudido P, Gian C-Z, Toosi Z. Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus. J Acquir Immune Syndr 1994;7:727-33.
11. Whalen C, Horsburgh CR, Horn D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995;151:129-35.
12. Chaulet P. The anti-tuberculosis campaign throughout the world: strategies and actions in the field. Respiration 1990;57:145-59.
13. Bothwell TH, Seftel H, Jacobs P, Torrance JD. Iron overload in Bantu subjects: studies on the availability of iron in Bantu beer. Am J Clin Nutr 1964; 14: 47-51.
14. Gordeuk VR, Mukiibi J, Hassted SJ, Samowitz W, Edwards CQ, West G, et al. Iron overload in Africa: interaction between a gene and dietary iron content. N Engl J Med 1992;326:95-100.
15. Strachan AS. Haemosiderosis and haemochromatosis in African natives with a comment on the aetiology of haemochromatosis. MD thesis. University of Glasgow, Glasgow, Scotland; 1929.
16. Bothwell TH, Bradlow BA. Siderosis in the Bantu: a combined histopathological and chemical study. Arch Pathol 1960;70:279-92.
17. Buchanan WM. Bantu siderosis with special reference to Rhodesian Africans. University College of Rhodesia Faculty of Medicine Research Series 1967;1:5-30.
18. MacPhail AP, Simon MO, Torrance JD, Charlton RW, Bothwell TH, Isaacson C. Changing patterns of dietary iron overload in black South Africans. Am J Clin Nutr 1979;32:1272-8.
19. Gordeuk VR, Boyd RD, Brittenham GM. Dietary iron overload persists in rural sub-Saharan Africa. Lancet 1986;1:1310-3.
20. Friedman BM, Baynes RD, Bothwell TH, Gordeuk VR, MacFarlane BJ, Lamparelli RD, et al. Dietary iron overload in southern African rural Blacks. S Afr Med J 1990;78:301-5.
21. Gordeuk VR. Hereditary and nutritional iron overload. Balliere's Clin Haematol 1992;5:169-9.
22. Isaacson C, Seftel HC, Keely KJ, Bothwell TH. The relationship between iron overload and cirrhosis: J Lab Clin Med 1961;58:845-53.
23. Seftel HC, Mlakin C, Schmaman A, Abrahams C, Lynch SR, Charlton RW, et al. Osteoporosis, scurvy and siderosis in Johannesburg Bantu. Br Med J 1966;1:642-6.
24. Seftel HC, Keeley KC, Isaacson C, Bothwell TH. Siderosis in the Bantu, the clinical incidence of haemochromatosis in diabetic subjects. J Lab Clin Med 1961;58:837-44.
25. Buchanan WM. Peritonitis and Bantu siderosis. S Afr Med J 1970;44:43-4.
26. Robins-Browne RM, Rabson AC, Koornhof HG. Generalised infection with Yersinia enterocolitica and the role of iron. Contrib Microbiol Immunol 1979;5:277-82.
27. Bothwell TH, Adams EB, Simon M, Isaacson C, Simjee AE, Kallichurum S, et al. The iron status of Black subjects with hepatic amoebiasis. S Afr Med J 1984;85:601-4.
28. Raghu B, Raghupati Sarma G, Venkatesan P. Effect of iron on the growth and siderophore production of mycobacteria. Biochem Mol Biol Internat 1993;31:341-8.
29. Ratledge C. Iron metabolism in mycobacteria. In: Winkelman G, Van der Helm J, Neilands JB, editors. Iron transport in microbes plants and animals. VCH Verlagsgesellschaft, Weinheim, 1987: p 207-22.
30. Stephenson MC, Ratledge C. Iron transport in Mycobacterium smegmatis: uptake of iron from ferriexochelin, J Gen Microbiol 1979;110:193-202.
31. Neilands JB, Konopka K, Schywn B, Coy M, Francis RT, Paw BH, et al. Comparative biochemistry of microbial iron assimilation. In: Winkelmann G, Van der Helm D, Neilands JB, editors. Iron transport in microbes plants and animals. VCH Verlagsgesellschaft, Weinheim, 1987:3- 34.
32. Sritharan M, Ratledge C. Co-ordinated expression of the components of iron transport (mycobactin, exochelin and envelope proteins) in Mycobacterium neonarum Ferns Microbiol (Letters) 1989;51:183-5.
33. Kochan I, Palton C, Isak K. Tuberculostatic activity of normal sera. J Immunol 1963;90:711-9.
34. Kochan I. Role of iron in the regulation of nutritional immunity. In: Reynolds KN, editor. Advances in chemistry. Washington DC, American Chemical Society, 1977:55-77.
35. Winder FG, Barber DS. The effect of hydroxyurea, nalidixic acid and zinc limitation on DNA polymerase and ATP-dependent deoxyribonuclease activities of Mycobacterium smegmatis. J Gen Microbiol 1973;76:189-96.
36. Dannenberg AM Jr, Tomashefski JF Jr. Pathogenesis of pulmonary tuberculosis. In: Fishman AP, editor. Pulmonary diseases and disorders, 2nd ed. New York: McGraw-Hill, 1988:1821-42.
37. Dannenberg AM Jr. Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Rev Inf Dis (Suppl) 1989; 11:5369-78.
38. Rook GA. Macrophage and Mycobacterium tuberculosis: the key to the pathogenesis. Immunal Series 1994;60:249-61.
39. Bothwell TH, Charlton RW, Cook JD, Finch CA. Clinical estimation of body iron stores. In: Iron metabolism in man. Oxford:Blackwell Scientific, Oxford 1979:88-95.
40. Byrd TF, Horwitz MA. Interferon-gamma activated monocytes downregulate transferrin receptor and inhibit the intracellular multiplication of L. pneumophila by limiting the availability of iron. J Clin Invest 1989;83:1457-65.
41. Taetle R, Honeysett JM. IFN-g modulates human monocyte/macrophage transferrin receptor expression. Blood 1988;71:1590-5.
42. Byrd TF, Horwitz MA. Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Co-ordinate upregulation by iron transferrin and downregulation by interferon gamma. J Clin Invest 1993;91:969-76.
43. Nathan C, Murray HW, Wiebe E, Rubin BY. Identification Interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983; 158:670-89.
44. Byrd TF, Horwitz MA. Lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in non-activated and interferon-gamma-activated human monocytes depending upon its degree of iron saturation. Iron lactoferrin and non physiologic iron chelators reverse monocyte activation against Legionella pneumophila. J Clin Invest 1991;88:1103-12.
45. Lane TE, Wu-Hsieh BA, Howard DH. Iroń limitation and the gamma interferon-mediated antihistoplasma state of murine macrophages. Infect Immun 1991;59:2274-8.
46. James SL, Glaven J. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependant production of reactive nitrogen intermediates. J Immunol 1989; 143:4208-12.
47. Alford CE, King TE Jr, Campbell PA. Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity. J Exp Med 1991;174:459-66.
48. Mauel J, Ransijn A, Buchmuller-Rouiller Y. Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine dependant process that produces nitrogen derivatives. J Leukocy Biol 1991;49:73-82.
49. Vincendeau P, Dalouede S. Macrophagecytostatic effect on T. musculi involves an L-Arginine dependant mechanism. J Immunol 1991;146:4338-43.
50. Buchmuller-Rouiller Y, Corradin SB, Mauel J. Macrophageactivation for intracellular killing is induced by a CA2* ionophore. Dependance on L-arginine-derived nitrogen oxidation products. Biochem J 1992;284:387-92.
51. Denis M, Ghadirian E. Activated mouse macrophages kill Entamoeba histolytica trophozoites by releasing reactive nitrogen intermediates. Microbial Pathol 1992;12:193-8.
52. Douvas GS, May MH, Crowle AJ. Transferrin, iron, and serum lipids enhance or inhibit Mycobacterium avium replication in human macrophages. J Infect Dis 1993;167: 857-64.
53. Denis M. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cellul Immunol 1991;132:150-7.
54. Weiss G, Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, et al. Iron inhibits interferon-gamma effects in the human myelomonocytic cell tine THP-1. Exp Haematol 1992;20:605-10.
55. Weiss G, Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, et al. Neopterin modulates toxicity mediated by reactive oxygen and chloride species. FEBS Letters 1993;321:89-92.
56. Weinberg ED. Iron depletion: defense against intracellular infection and neoplasia. Science 1992;50:1289-97.
57. Lancaster JR, Hibbs JB. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci USA 1990;87:1223-7.
58. Pellat C, Henry Y, Drapier J-C. IFN-gamma-activated macrophages: detection by electron paramagnetic resonance of complexes between L-arginine-derived nitric oxide and non-heme iron proteins. Biochem Biophys Res Commun 1990;166:119-25.
59. Lepper AW, Jarrett RG, Lewis VM. The effect of different levels of iron intake on the multiplication of Mycobacterium tuberculosis in C57 and C3H mice. Vet Microbiol 1988; 16:369-83.
60. Bothwell TH, Abrahams C, Bradlow BA, Charlton RW. Idiopathic and Bantu haemochromatosis. Arch Pathol 1965;79:163-8.
61. Gordeuk VR, MacPhail AP, McLaren CE, Deichsel G, Bothwell TH. Associations of iron overload in Africa with hepatocellular carcinoma and tuberculosis: Strachan's 1929 thesis revisited. Blood 1996;87:3470-6.
62. Learmonth G, Marks RR, Hunt J, Narramore C. The cytopathological recognition of African siderosis on bone smears. Cytopath 1991;2:205-13.
63. Kaufmann SH. The macrophage in tuberculosis: sinner or saint? The T-cell decides. Pathobiol 1991;59:153-5.
64. Rose RM. Immunobiology of the lung in HIV infection; the pathophysiologic basis for the development of tuberculosis in the AIDS setting. Bull Int Against Tubercul Lung Dis 1991;66:15-20.
65. Gelman BB, Rodriquez-Wolfe MG, Wen J, Kumar S, Campbell GR. Siderotic cerebral macrophages in AIDS. Arch Pathol Lab Med 1992; 1:509-16.